Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Targets & Mechanisms

New targets featured at AACR signal growing opportunity in established mechanisms

Protein degraders, ion channel regulators and novel checkpoints are among new targets presented at AACR21

April 16, 2021 7:53 PM UTC

The bulk of the new targets presented at AACR21 involve pathways and mechanisms active in tumor cells rather than immune cells, reflecting the biotech industry’s growing interest in targeted oncology and precision medicine.

BioCentury’s analysis of the abstracts presented at the American Association for Cancer Research (AACR) annual meeting identifies 47 new targets that aren’t addressed by any cancer programs in clinical or preclinical development, according to BioCentury’s BCIQ database. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article